The ‘Tookie Vest for Renal’ – A North East and North Cumbria Innovation Pathway Partnership Case Study

In early 2016 MedConnecT North introduced Tookie to Dr Saeed Ahmed, Interventional Consultant Nephrologist at City Hospitals Sunderland NHS Foundation Trust who was intrigued by Tookie as he himself was looking for the same outcomes but from a clinical perspective. The meeting considered the potential of adapting the Tookie vest, originally designed to prevent inadvertent catheter fall out in paediatric oncology patients, for use in adult Haemodialysis (HD) patients. An adapted vest would hopefully be able to support patients fitted with a Central Venous Catheter (CVC) to provide enhanced line security and patient well-being in treatment – ‘#ALifeMoreNormal’. (Tookie’s main ethos)

Vascular access is essential for providing adequate haemodialysis, which is ultimately a life-saving therapy. Complications of CVC use are well documented especially that of inadvertent catheter displacement with around 20% of patients affected. Each line re-instatement costs the NHS approximately £3,000.00, whilst also affecting the patient’s quality of life.

Contact Details

Project Dates

Project Start 01/05/2016
Project End Ongoing

Programmes

Share

Download PDF

The impact of this regional collaboration will allow all suitable patients equity of access to the new Renal Vest, to help them lead #ALifeMoreNormal. We are most grateful to all everyone involved in this project and a privilege to work in the North East; with special thanks to Dr Saeed Ahmed.
Mr Stephen Tooke, Commercial Director, Tookie Limited
Show/hide all

One of the main challenges which had been encountered was redesigning the original vest for a new patient population. To overcome this, City Hospitals Sunderland’s renal research team (Dr Saeed Ahmed, Dr Rachel Davison, Paul Corrigan and Debbie Sweeney) and the Research and Innovation (R&I) department (Mr Kim Hinshaw, Lynne Palmer and Emily Brand) supported by MedConNecTNorth subsequently arranged for the Tookie team to hold patient centred focus groups to re-design the vest and create an adaptable product that could be used within this patient population. Focus groups took place during which time many prototypes were considered by the research team and with the final design now agreed it is being CE Marked in preparation for a qualitative and quantitative evaluation study.

The Tookie Vest is an innovation which has been designed to support patients fitted with a Central Venous Catheter to provide enhanced line security. The Tookie Vest is designed to help prevent catheter displacement but also to help the patients to continue to live ‘#ALifeMoreNormal’ as the vest helps to discretely secure the lines offering modesty and dignity, freedom, independence and reassurance.

Between May 2016 and March 2017, Tookie Limited, City Hospital Sunderland’s Renal Team & Research and Innovation Team supported by MedConnecT North ran patient focus groups to re-design the current paediatrics vest for use in the Renal adult population. The Renal vest has been through various prototypes and now the final design when CE Marked will be ready for a NIHR CRN Portfolio Adopted evaluation study; sponsored by City Hospital Sunderland NHS Foundation Trust.

The next step currently underway is the design of a proof of concept pilot study. The multi-centre study will aim to explore the un-met need of the renal patient to provide a suitable wearable vest to improve their Quality of Life (QoL) and enhance mechanisms that enable the efficient delivery of their treatment. The study will also assess the impact of the garment on clinical outcomes i.e. fall out rates.

Specialist NIHR CRN Researchers have been drafted in to strengthen the Research Team and to begin writing the evaluation study protocols in preparation of the next phase of work.

The impact on a patient is an increase in comfort, line security and modesty.

The financial benefits are being reviewed within a wider evaluation however, what is known at this stage is that 20% of patients become affected by inadvertent line fall out and that each line re-instatement costs the NHS approximately £3,000.00. The intervention of this innovation will hopefully help in reducing the amount of line re-instatements required and the study will inform the understanding of its value proposition to the NHS.

YH AHSN (£15,000.00 Funding)

GM AHSN (£10,000.00 Funding)

Innovation Agency (NW Coast AHSN – ERDF Funding)